Assessing the Impact of a Clinical Pharmacist in a Postsurgical Inpatient Population.
J Pharm Pract. 2020 Jul 21;:897190020938196
Authors: Tavakoli FC, Adams-Sommer VL, Frendak LS, Kiehle ND, Dalpoas SE
OBJECTIVE: To quantify the number and type of clinical pharmacist interventions with an impact on patient care in a postsurgical nonintensive care patient population.
BACKGROUND: Studies have shown that pharmacists are able to improve the quality of patient care; however, the pharmacist role in postsurgical nonintensive care areas is not well defined.
METHODS: A clinical pharmacist provided care for 2 postsurgical floors for 2 weeks and collected information about the number and type of interventions made and adverse events avoided. In addition, the study team conducted an anonymous survey amongst the multidisciplinary team who collaborated with the pharmacist at the end of the trial period to understand the perception of having access to a clinical pharmacist who was designated to their floor.
RESULTS: In a 2-week time period, the clinical pharmacist was able to make 218 interventions, including 38 recommendations for optimization of antimicrobials, 26 recommendations for anticoagulation optimization, and providing education for 20 patients planned for discharge on high-risk medications. Interventions made by the clinical pharmacist helped decrease adverse events, improve patient safety and knowledge, and potentially avoid readmissions and reduce hospital length of stay. The survey results revealed that 100% strongly agreed that a clinical pharmacist should be a member of the multidisciplinary team for the postsurgical floors.
CONCLUSION: This data signifies that having a clinical pharmacist dedicated to the postsurgical patient population allows for optimization of antimicrobial and anticoagulant use, improves outcomes for patients through medication education, and enhances provider satisfaction.
PMID: 32691662 [PubMed - as supplied by publisher]